Click here to go to the previous page
Managing CV Risk in Type 2 Diabetes
Program Code:
M17
Date:
Sunday, June 5, 2011
Time:
8:30 AM to 9:15 AM
EST
SPEAKER
:
Samuel Dagogo-Jack, MD,FRCP, Univ of Tennessee-Memphis
Disclosures: SD-J: Speaker, Eli Lilly & Company, GlaxoSmithKline; Consultant, Merck & Co., Roche Pharmaceuticals; Principal Investigator, Astra Zeneca, Bristol-Myers Squibb.